Executive Director, Global Site Management
Regeneron Pharmaceuticals
Summary
The Executive Director, Global Site Management provides enterprise-level strategic leadership and organizational accountability for global site-facing capabilities. The role sets the global vision and operating strategy for site management, monitoring execution, resource and budget planning, and CRO/FSP/vendor performance across the clinical development portfolio.
Job description
Discover your role
- Establish and advance the global strategy for country key opinion leader, investigator, and site relationships
- Set direction and governance for global study execution, clinical site monitoring, and issue escalation across the portfolio
- Sponsor risk-based, study-specific monitoring strategies and ensure their consistent implementation and effectiveness
- Define enterprise performance, quality, compliance, and productivity expectations for site management and monitoring activities
- Champion standardization, digital enablement, innovation, and measurable value creation across the global operating model
- Own the global workforce and capability strategy for site management, including multi-year FTE and external-capacity forecasts, headcount planning, allocation, utilization, leadership development, and succession across CTL and CRA organizations
- Hold executive accountability for the global vendor strategy, CRO/FSP contracting worth $10M for CRAs and $10M for CTLs, associated investment, capacity, and performance
- Lead senior-level vendor governance, commercial and operational decisions, and corrective interventions when performance or quality is at risk
- Oversee management of data and quality issues at the country/site level, partnering with study management, data management, Quality Management Leads and other stakeholders
- Partner with Global Monitoring Oversight, Central Monitoring, Vendor Relationship Management and counterparts at CROs to ensure alignment on risk-based monitoring strategies, standards and training requirements
- Serve as the enterprise thought leader and senior subject matter authority for global site management
- Establish the global CTL capability model, accountabilities, standards, and measures that support study feasibility, site identification and selection, patient recruitment and retention, and resolution of complex investigator-site issues
This role requires
- Minimum Bachelors Degree (Advanced Degree preferred) with 17+ years of experience including 10+ years of functional leadership and people management
- Expert knowledge of drug development, global clinical operations, clinical monitoring, site management, GCP, and applicable regulations
- Extensive experience leading global clinical trial operations and enterprise transformation across multiple therapeutic areas, regions, and development stages
- Experience working with/establishing global clinical site relationships; cross cultural awareness and fluent in Business English
- Proven executive leadership in setting vision, leading through ambiguity, building high-performing global organizations, developing senior talent, shaping culture, and delivering sustained change at scale
- Demonstrated success leading leaders and managing performance across global, matrixed, and partner-based organizations
- Executive presence and exceptional communication, influence, negotiation, and decision-making skills
- Excellent interpersonal skills and demonstrated collaborative as well as independent working style
- Proactive and self-motivated, ability to align activities with the clinical development plans (CDPs)
- Strong organizational skills with effective use of time and prioritization
Requirements
- Minimum Bachelors Degree (Advanced Degree preferred)
- 17+ years of experience
- 10+ years of functional leadership and people management
- Expert knowledge of drug development, global clinical operations, clinical monitoring, site management, GCP, and applicable regulations
- Extensive experience leading global clinical trial operations and enterprise transformation across multiple therapeutic areas, regions, and development stages
- Experience working with/establishing global clinical site relationships
- Cross cultural awareness and fluent in Business English
- Proven executive leadership in setting vision, leading through ambiguity, building high-performing global organizations, developing senior talent, shaping culture, and delivering sustained change at scale
- Demonstrated success leading leaders and managing performance across global, matrixed, and partner-based organizations
- Executive presence and exceptional communication, influence, negotiation, and decision-making skills
- Excellent interpersonal skills and demonstrated collaborative as well as independent working style
- Proactive and self-motivated, ability to align activities with the clinical development plans (CDPs)
- Strong organizational skills with effective use of time and prioritization
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical, Dental & Vision
- Life and disability insurance
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.